on 19 Nov 2024
Last Applicant/ Owned by
Changshu, Suzhou 215500
CN
Serial Number
79376322 filed on 13th Jun 2023
Registration Number
N/A
Correspondent Address
Stephanie Goeller
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Research and development of new pharmaceutical products, such as antibodies, antibody-drug conjugates, fusion proteins and other recombinant proteins; providing information with respect to medical and scientific research in the field of pharmaceutical products; pharmaceutical research and development services; consultation with respect to pharmaceutical research; medical research; scientific resea Read More
Research and development of new pharmaceutical products, such as antibodies, antibody-drug conjugates, fusion proteins and other recombinant proteins; providing information with respect to medical and scientific research in the field of pharmaceutical products; pharmaceutical research and development services; consultation with respect to pharmaceutical research; medical research; scientific research services for medical purposes in the field of pharmaceuticals; biomedical research services; scientific and medical research and development, namely, research and development in the field of medical preparations; design and development of testing and analysis methods for new pharmaceutical product development; scientific research in the nature of conducting clinical trials for others; analysis and evaluation of newly developed pharmaceutical products, such as antibodies, antibody-drug conjugates, fusion proteins and other recombinant proteins; analysis and evaluation of newly designed pharmaceutical products, such as antibodies, antibody-drug conjugates, fusion proteins and other recombinant proteins; stem cell research services; scientific research services for medical purposes in the field of proteins, antibodies, microorganisms and cells; product research; providing medical and scientific research information in the field of pharmaceutical products and clinical trials; providing information on the results of clinical research trials for pharmaceutical products; consultation with respect to pharmaceutical research and development; providing integrated development of pharmaceutical products, namely, research and development of pharmaceutical products, and scientific research in the nature of conducting clinical trials and studies for others
N/A
N/A
Pharmaceutical products for treating cancer, autoimmune disorders, infectious diseases and cardiovascular, pulmonary and neurological conditions; medical preparations for the treatment of cancer, autoimmune disorders, infectious diseases and cardiovascular, pulmonary and neurological conditions; veterinary preparations for vaccinating livestock; disinfectants; preparations for destroying vermin; fungicides; herbicides; dietetic food and beverages adapted for medical use; dietetic pet foods and beverages for veterinary use; food for babies; food supplements; medical plasters, medical dressings; medicines for treating cancer, autoimmune disorders, infectious diseases and cardiovascular, pulmonary and neurological conditions
N/A
N/A
Active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer, autoimmune disorders, infectious diseases and cardiovascular, pulmonary and neurological conditions; chemicals for use in industry and science; reagents for scientific apparatus for chemical or biological analyses being reagents for scientific and research use; protein in raw material form for scientific and medical research; biochemicals for in-vitro and in-vivo scientific use; biological preparations for use in industry and science; chemical preparations for use in industry; catalysts for chemical processes; diagnostic preparations for scientific use; diagnostic reagents for science or research use; stem cells for research purposes
N/A
N/A
No 79376322
No Service Mark
No 5946.0001
No
No
No
No
Yes
Yes
No
No
Status Date | Action Taken |
---|---|
19th Nov 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
19th Nov 2024 | PUBLISHED FOR OPPOSITION |
13th Nov 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
05th Oct 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
16th Sep 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
16th Sep 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
16th Sep 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
23rd Apr 2024 | REFUSAL PROCESSED BY IB |
04th Apr 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
04th Apr 2024 | REFUSAL PROCESSED BY MPU |